Online citations, reference lists, and bibliographies.
← Back to Search

Gene Expression By Single Reed-Sternberg Cells: Pathways Of Apoptosis And Activation

Christina Messineo, M. H. Jamerson, E. Hunter, R. Braziel, A. Bagg, S. G. Irving, J. Cossman
Published 1998 · Biology

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Although Hodgkin's disease is highly responsive to treatments that cause apoptosis, it remains resistant to the physiological mechanisms intended to cause cell death. Presumably, the Reed-Sternberg cell defies endogenous apoptosis, persists, accumulates, and manifests the malignant disorder seen clinically. The Reed-Sternberg cell expresses several members of the tumor necrosis factor receptor superfamily. This family of receptors is involved in both activation and proliferation of cells, as well as either protection from or initiation of apoptosis in cells expressing these surface proteins. Signals from these receptors affect transcription. We reasoned that the activation state and resistance to apoptosis of Reed-Sternberg cells might be attributable to dysregulation of genes controling these processes. To determine gene expression by Reed-Sternberg cells, we developed a method of micromanipulation, global reverse transcription, and the reverse transcription-polymerase chain reaction and applied it to 51 single Reed-Sternberg cells and their variants from six cases of Hodgkin's disease. This report analyzes the gene expression of bcl-xs , bcl-xl , bax -α, bax -β, fadd , fas , fas ligand ( fas L ), ice , TNF -α, TNF -β, TNFR1 , TNFR2 , TRAF1 , TRAF2 , TRAF3 , cIAP2 , and tradd at the level of mRNA in the single Reed-Sternberg cells and their variants. The findings here suggest a molecular mechanism for the activated state and in vivo survival occurring in untreated Reed-Sternberg cells of Hodgkin's disease.
This paper references
10.1073/PNAS.93.24.14053
Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.
S. Ansieau (1996)
10.1002/j.1460-2075.1990.tb07526.x
Soluble forms of tumor necrosis factor receptors (TNF‐Rs). The cDNA for the type I TNF‐R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.
Y. Nophar (1990)
10.1182/BLOOD.V86.10.3848.BLOODJOURNAL86103848
Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle.
Y. Komada (1995)
10.1083/JCB.124.1.1
Bcl-2 and the regulation of programmed cell death
J. C. Reed (1994)
10.1084/JEM.181.1.71
Fas ligand mediates activation-induced cell death in human T lymphocytes
M. Alderson (1995)
10.1016/0092-8674(93)90509-O
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Zoltán N. Oltval (1993)
10.1182/BLOOD.V80.9.2336.BLOODJOURNAL8092336
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry.
P. Brons (1992)
10.1093/NAR/12.3.1687
Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.
P. Ponte (1984)
10.1016/0092-8674(95)90013-6
Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
G. H. Fisher (1995)
10.1128/MCB.16.12.7098
Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
O. Devergne (1996)
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
T. Stalder (1994)
Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells.
Z. Wang (1995)
10.1093/INTIMM/6.10.1545
Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.
F. Ramsdell (1994)
10.1182/BLOOD.V85.10.2671.BLOODJOURNAL85102671
High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease.
D. Schlaifer (1995)
10.1016/0092-8674(95)90149-3
The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
M. Rothe (1995)
10.1093/NAR/13.17.6361
Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.
G. Nedwin (1985)
10.1016/0092-8674(91)90614-5
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
N. Itoh (1991)
10.1080/09553008814550431
Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis).
T. Yamada (1988)
10.1038/356768A0
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Nancy A. Thornberry (1992)
10.1016/S0092-8674(94)90422-7
Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death
Lin Wang (1994)
10.1016/0092-8674(95)90411-5
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
E. Yang (1995)
10.1016/0022-1759(82)90302-7
T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations.
R. Falkoff (1982)
10.1093/AJCP/75.5.734
A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.
S. Hsu (1981)
10.1016/0092-8674(95)90071-3
FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis
A. Chinnaiyan (1995)
10.1038/374736A0
Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak
M. Kiefer (1995)
10.1016/S0092-8674(00)81266-0
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
M. Muzio (1996)
10.1016/0092-8674(94)90532-0
A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
M. Rothe (1994)
10.1126/science.274.5288.784
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
C. Y. Wang (1996)
10.1126/SCIENCE.7518614
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.
D. Kägi (1994)
10.1016/0008-8749(92)90187-T
DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.
L. Owen-Schaub (1992)
10.1073/PNAS.87.21.8331
A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.
T. Kohno (1990)
10.1073/PNAS.94.6.2460
Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB
T. L. Vanarsdale (1997)
The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
D. Güssow (1987)
10.1007/BF02592274
Epstein-Barr virus and hodgkin’s disease
H. Herbst (1993)
10.1038/375078A0
Involvement of an ICE-like protease in Fas-mediated apoptosis
M. Enari (1995)
CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth.
T. Ishida (1995)
10.1126/science.274.5288.787
Suppression of TNF-α-Induced Apoptosis by NF-κB
D. V. Van Antwerp (1996)
10.1126/science.274.5288.782
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
A. Beg (1996)
10.1038/NM0596-574
Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells
C. Friesen (1996)
10.1038/374733A0
Induction of apoptosis by the Bcl-2 homologue Bak
T. Chittenden (1995)
10.1016/s0021-9258(18)47344-9
CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.
T. Fernandes-Alnemri (1994)
10.1016/0014-5793(94)01406-Q
A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40
T. Sato (1995)
Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
S. Kaufmann (1989)
10.1038/356314A0
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
R. Watanabe-Fukunaga (1992)
10.1182/BLOOD.V81.11.3097.3097
Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations
L. Trümper (1993)
10.1126/science.7533327
Involvement of CRAF1, a relative of TRAF, in CD40 signaling
G. Cheng (1995)
10.1016/0092-8674(93)90486-A
Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
M. Miura (1993)
10.1073/PNAS.90.21.10340
The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
J. Drappa (1993)
10.1016/0092-8674(94)90375-1
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Tomohiro Takahashi (1994)
10.1182/BLOOD.V87.6.2470.BLOODJOURNAL8762470
Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease.
P. Brousset (1996)
10.1016/0092-8674(93)90326-L
Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
T. Suda (1993)
10.1016/0092-8674(95)90489-1
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
G. Mosialos (1995)
10.1084/JEM.184.4.1495
Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
H. Kanzler (1996)
10.1016/0092-8674(93)90508-N
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
L. Boise (1993)
10.1016/0006-2952(90)90733-2
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia.
M. Barry (1990)
10.1182/BLOOD.V85.12.3378.BLOODJOURNAL85123378
Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas.
H. Gruss (1995)
10.1016/0092-8674(95)90070-5
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
H. Hsu (1995)
10.1073/PNAS.93.18.9437
TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.
T. Ishida (1996)
10.1111/j.1365-2559.1995.tb00215.x
Frequent expression of FAS/APO‐1 in Hodgkin's disease and anaplastic large cell lymphomas FAS/APO‐1 in Hodgkin's disease and anaplastic large cell lymphomas
L. Xerri (1995)
10.1073/PNAS.90.5.1756
Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.
M. Adachi (1993)
10.1016/S0092-8674(00)80984-8
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways
H. Hsu (1996)
10.1042/BJ3090825
Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor.
H. Y. Song (1995)



This paper is referenced by
10.1016/S0301-472X(99)00125-3
Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.
Daniel Re (2000)
10.1073/PNAS.97.2.799
Intestinal trefoil factor confers colonic epithelial resistance to apoptosis.
D. Taupin (2000)
10.1097/00001622-199909000-00007
The dynamics of life and death of malignant lymphocytes.
A. Younes (1999)
10.1006/CYTO.1998.0449
CD27 signals through PKC in human B cell lymphomas.
B. Erlichman (1999)
10.2217/BMM.15.30
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma.
C. Carlo-Stella (2015)
10.1016/S0301-472X(01)00627-0
Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
T. Wrone-Smith (2001)
10.1111/j.1699-0463.1999.tb01453.x
Apoptosis‐related genes and proteins in Hodgkin's disease
A. F. Lauritzen (1999)
Postępy w biologii i leczeniu chłoniaka Hodgkina
K. Warzocha (2005)
10.1182/BLOOD.V96.8.2841.H8002841_2841_2848
Hodgkin disease: pharmacologic intervention of the CD40-NFκB pathway by a protease inhibitor
C. Annunziata (2000)
10.1182/BLOOD.V97.9.2798
Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.
M. Hinz (2001)
10.1016/S0145-2126(99)00108-3
Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh.
N. Wall (1999)
10.1038/sj.onc.1203177
Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease
H. Knecht (1999)
10.1016/S0002-9440(10)64583-X
Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.
F. Raaphorst (2000)
10.1038/modpathol.3880243
Expression of the Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells
Keith F. Izban (2000)
10.1002/HON.659
The Reed–Sternberg cell in classical Hodgkin's disease
W. Chan (2001)
10.3109/07357900009012202
Apoptosis and Cell Proliferation Capacity in AKR Lymphoma Malignancy Variants
N. Donin (2000)
Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas.
M. Bai (2005)
10.1074/JBC.M001202200
Involvement of Two NF-κB Binding Elements in Tumor Necrosis Factor α-, CD40-, and Epstein-Barr Virus Latent Membrane Protein 1-mediated Induction of the Cellular Inhibitor of Apoptosis Protein 2 Gene*
S. Hong (2000)
10.1182/BLOOD.V93.8.2688.408K01_2688_2696
Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma.
R. L. ten Berge (1999)
10.1053/ADPA.2000.17893
Evolving concepts of the nature of Hodgkin's disease: a history.
C. Taylor (2000)
10.1016/S0959-8049(99)00117-3
Paediatric Hodgkin's disease.
R. Poetter (1999)
10.1046/j.1365-2141.2002.03732.x
Hodgkin and Reed–Sternberg cells express functional c‐kit receptors and interact with primary fibroblasts from Hodgkin's disease‐involved lymph nodes through soluble and membrane‐bound stem cell factor
D. Aldinucci (2002)
10.1177/002215540104900617
Gene Expression Analysis of Single Neoplastic Cells and the Pathogenesis of Hodgkin's Lymphoma
J. Cossman (2001)
10.1128/JVI.77.2.1316-1328.2003
TRAF1 Is a Critical Regulator of JNK Signaling by the TRAF-Binding Domain of the Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1 but Not CD40
A. Eliopoulos (2003)
10.1002/(SICI)1096-9896(200004)190:5<604::AID-PATH561>3.0.CO;2-P
Apoptosis of malignant cells in Hodgkin's disease is related to expression of the cdk inhibitor p27KIP1
Z. Kolář (2000)
Semantic Scholar Logo Some data provided by SemanticScholar